Abivax (AAVXF) Stock Price, News & Analysis
Company Description
Abivax (OTC Link: AAVXF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $9.6B.
AAVXF has gained 1809.3% over the past year. Shares last traded at $139.00.
This page collects what Stock Titan holds for AAVXF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Abivax (AAVXF) stock last closed at $139.00. Over the past 12 months, the stock has gained 1809.3%. At a market capitalization of $9.6B, AAVXF is classified as a mid-cap stock with approximately 79.1M shares outstanding.
Latest News
SEC Filings
Abivax has filed 5 recent SEC filings, including 2 Form 6-K, 2 Form 424B5, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on July 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AAVXF SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Abivax (AAVXF) currently stands at 135.0 thousand shares, up 357.4% from the previous reporting period, representing 0.2% of the float. Since July 2025, short interest has increased by 135.6%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Abivax (AAVXF) currently stands at 1000.0 days, up 15500.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 34029.4% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
AAVXF Company Profile & Sector Positioning
Abivax (AAVXF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.